Evaluation of the Effectiveness of Two Morphine Protocols to Treat Neonatal Abstinence Syndrome in a Level II Nursery in a Community Hospital

التفاصيل البيبلوغرافية
العنوان: Evaluation of the Effectiveness of Two Morphine Protocols to Treat Neonatal Abstinence Syndrome in a Level II Nursery in a Community Hospital
المؤلفون: Michelle DeLuca Fraley, Heather N. DeAtley, Amanda Burton, Joan Haltom
المصدر: Pharmacotherapy. 37(7)
سنة النشر: 2017
مصطلحات موضوعية: medicine.medical_specialty, Average duration, Treatment duration, Administration, Oral, Hospitals, Community, 03 medical and health sciences, 0302 clinical medicine, Neonatal abstinence, 030202 anesthesiology, Pregnancy, 030225 pediatrics, medicine, Humans, Pharmacology (medical), Neonatology, Retrospective Studies, Morphine, business.industry, Morphine treatment, Infant, Newborn, Opioid-Related Disorders, Community hospital, Nurseries, Hospital, Treatment Outcome, Anesthesia, Prenatal Exposure Delayed Effects, Female, Level ii, business, Neonatal Abstinence Syndrome, medicine.drug
الوصف: The authors sought to evaluate the impact on length of hospital stay and treatment duration of morphine after implementation of a change in the institutional protocol for managing neonatal abstinence syndrome (NAS) in an effort to improve patient outcomes. A single-center, retrospective chart review was conducted at a Level II nursery in a community hospital in Kentucky. Fifty-nine neonates born between January 1, 2014, and December 31, 2015, who were diagnosed with NAS and received morphine for treatment were included. The protocol 1 group consisted of 33 neonates who received an initial dose of morphine 0.04 mg/kg/dose administered orally every 4 hours (January 1-December 31, 2014), and the protocol 2 group consisted of 26 neonates who received an initial dose of morphine 0.06 mg/kg/dose administered orally every 3 hours (January 1-November 30, 2015), after a change in the protocol for managing NAS was implemented on January 1, 2015. Data were reviewed and compared between the two protocol groups to determine the impact that the dosage change had on length of hospital stay and morphine treatment duration. The average length of stay decreased by 7 days in the protocol 2 group compared with the protocol 1 group (21 vs 28.65 days). The average duration of treatment decreased by 7 days in the protocol 2 group compared with the protocol 1 group (18.3 vs 25.4 days). These differences between groups were not statistically significant, however, because the population size was not large enough to achieve adequate power. These results indicate that protocol 2 displayed the potential to decrease length of stay and duration of treatment compared with protocol 1 at this facility; however, balancing higher starting doses with the risk of oversedation will continue to challenge the health care team. Concern for oversedation when using the higher starting dose in protocol 2 has prompted further research (e.g., protocol 3, initial morphine 0.05 mg/kg/dose every 3 hrs). Continued research is also necessary with larger patient populations to enable generalizability to other institutions.
تدمد: 1875-9114
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccc4aedf3d1c5b9ade150a06ece315e9
https://pubmed.ncbi.nlm.nih.gov/28949409
حقوق: CLOSED
رقم الأكسشن: edsair.doi.dedup.....ccc4aedf3d1c5b9ade150a06ece315e9
قاعدة البيانات: OpenAIRE